Clinical Trials
Protalix BioTherapeutics Announces Positive results from Phase II Clinical Trial of alidornase alfa
Protalix BioTherapeutics Inc announced positive interim results from the Company’s phase II clinical trial of alidornase alfa for the treatment of Cystic Fibrosis (CF)...
Articles
Clinical research data sharing promises new cures and treatments
Clinical research generates extensive amounts of data, yet most of it is siloed or generally unavailable to a larger pool of willing potential researchers.
If...
Clinical Trials
Allergan and Ironwood Report Topline Phase IIb Data Supporting Further Investigation of Linaclotide Colonic Release-2 (CR2)
Ronwood Pharmaceuticals and Allergan plc announced topline data from a Phase IIb clinical trial evaluating an investigational linaclotide colonic release-2 (CR2) formulation in adult...
Clinical Trials
Selexis SA and OSE Immunotherapeutics Collaborate to Advance Development of Immunotherapies for Cancer and Autoimmune Diseases
Selexis SA, a pioneering life sciences company and a global leader in mammalian (suspension-adapted CHO-K1) cell line generation, and OSE Immunotherapeutics SA announced the...
Clinical Trials
Genfit says FDA has officially cleared the IND to proceed with Phase II trial and evaluate elafibranor in PBC
GENFIT a biopharmaceutical company at the forefront of developing therapeutic and diagnostic solutions in metabolic and inflammatory diseases, that notably affect the liver or...
Clinical Trials
Spark Therapeutics and Pfizer Announce Updated Data from Hemophilia B Phase 1/2 Trial Suggesting Sustained Therapeutic Levels of Factor IX Activity
Spark Therapeutics and Pfizer Inc announced that Lindsey A. George, M.D a hematologist and attending physician at the Children’s Hospital of Philadelphia and lead...
Clinical Trials
Achilles Teutics launched with funds of £13.2 million to develop Immunotherapies for Cancer
SYNCONA LLP and CANCER RESEARCH TECHNOLOGY (CRT) announce the formation of Achilles Therapeutics Ltd .The new private company will bring together world-class research from...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read